Eliquis cost in 2026: Medicare’s negotiated price and the cash price
Medicare Part D pays $231 for 30 days of Eliquis in 2026; without insurance, a pharmacy pays about $331 for 60 tablets of 5 mg.
Eliquis (apixaban), the blood thinner taken twice a day, was the negotiated drug with the largest Part D spending, $18.3 billion in 2023 according to CMS, and 2026 is the first year its price is set by negotiation: Part D plans pay $231 for a 30-day supply, against a list price of $521 for 30 days in 2023 according to CMS. Under the standard benefit, a full year of Eliquis then costs you the $615 deductible and 25% of the rest, about $1,154 in total, far below the $2,100 cap. In 2027 the negotiated price is adjusted for inflation to $237. Without insurance there is no Bristol Myers Squibb or TrumpRx self-pay listing for Eliquis; what pharmacies pay, according to the NADAC survey of October 14, 2026, is about $331 for a month of 5 mg tablets, the floor of any counter price.
The whole of 2026, by way of paying
- Paying cash (self-pay)no published price
- Medicare Part D, covered use$1,154
- Medicaid, at a $4.00 copay$48
You would pay, Eliquis 5 mg twice a day
$96 / month
$1,154 in 2026
Standard 2026 Part D benefit: deductible, then 25% of the cost, below the yearly cap.
Same dose, other ways to pay (per month)
- List price (wholesale acquisition cost)not published
- What pharmacies pay (NADAC)$331
- Medicare negotiated price, 2026$231
- Medicare Part D, your share (month avg., 2026)$96
TrumpRx and makers read on October 16, 2026 · NADAC file of October 14, 2026. Estimate only, not medical advice. How it is calculated
Prices read by Radif Partners · Editorial policy · Method and data
What the negotiated price changes for you
Before 2026, a Part D plan paid its own contracted price for Eliquis and your 25% coinsurance followed that price. Since January 1, 2026, the plan’s cost and your share are computed on the $231 maximum fair price, whatever the strength, and the manufacturer makes the pharmacy whole for the difference with what it paid. People who pay a flat copay see less change than people who pay coinsurance. The cap matters less for Eliquis than for a GLP-1: twelve months at the negotiated price add up to $2,772, well under the amount that would trigger the $2,100 ceiling on its own.
| Tablet | Pharmacy cost, 60 tablets (NADAC) | Medicare 2026, 30 days | Medicare 2027, 30 days |
|---|---|---|---|
| 2.5 mg twice a day | $331 | $231 | $237 |
| 5 mg twice a day | $331 | $231 | $237 |
Without insurance
Eliquis is not among the drugs on TrumpRx, and its makers publish no cash price. The pharmacy’s acquisition cost is therefore the useful benchmark: the counter price adds a margin and a dispensing fee to it.
With Extra Help
People with low incomes who qualify for Extra Help pay a fixed copay per brand prescription instead of coinsurance: at most $12.65 in 2026 and $14.40 in 2027, and less for those with full Medicaid. The Extra Help page adds this up for several drugs.